Homegrown private equity (PE) firm CX Partners plans to sell part of its stake in Veeda Clinical Research Pvt. Ltd through an initial public offering (IPO) of ₹500-700 crore, two people aware of the development said on condition of anonymity.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
